Trial Profile
ESSENTIAL Protocol No. My-021 and Protocol No. My-026, Each Titled: A Phase III, Randomized, Double-Blind, Multicenter, Parallel Group, Placebo-Controlled Study of Oral Enoximone vs. Placebo in Advanced Chronic Heart Failure Subjects
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Enoximone (Primary)
- Indications Chronic heart failure
- Focus Registrational; Therapeutic Use
- Acronyms ESSENTIAL
- Sponsors Gilead Sciences
- 15 Jan 2014 New trial record